Literature DB >> 12507414

Autophagic vacuolar myopathies.

Ichizo Nishino1.   

Abstract

Hereditary myopathies characterized by the development of autophagic vacuoles can be categorized into three groups: rimmed vacuolar myopathies, acid maltase deficiency (glycogen storage disease type II), and myopathies characterized by the autophagic vacuoles with unique vacuolar membranes. Rimmed vacuolar myopathies are most likely secondary lysosomal myopathies because all of the identified causative genes encode extralysosomal proteins. Deficiency of acid maltase, a lysosomal enzyme, has been well characterized clinically, pathologically, biochemically, and genetically, and may become treatable in the near future. The diseases in the last category are relatively rare, but appear to be genetically heterogeneous and the list of these diseases is expanding. Danon disease, the best-characterized disorder in this group, is caused by primary deficiency of a lysosomal membrane protein, LAMP-2. Therefore, diseases in this category are expected to be primary lysosomal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507414     DOI: 10.1007/s11910-003-0040-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  17 in total

1.  Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy.

Authors:  I Nishino; S Noguchi; K Murayama; A Driss; K Sugie; Y Oya; T Nagata; K Chida; T Takahashi; Y Takusa; T Ohi; J Nishimiya; N Sunohara; E Ciafaloni; M Kawai; M Aoki; I Nonaka
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

2.  Infantile autophagic vacuolar myopathy is distinct from Danon disease.

Authors:  A Yamamoto; Y Morisawa; A Verloes; N Murakami; M Hirano; I Nonaka; I Nishino
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

3.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

4.  The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.

Authors:  I Eisenberg; N Avidan; T Potikha; H Hochner; M Chen; T Olender; M Barash; M Shemesh; M Sadeh; G Grabov-Nardini; I Shmilevich; A Friedmann; G Karpati; W G Bradley; L Baumbach; D Lancet; E B Asher; J S Beckmann; Z Argov; S Mitrani-Rosenbaum
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

5.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Authors:  I Nishino; J Fu; K Tanji; T Yamada; S Shimojo; T Koori; M Mora; J E Riggs; S J Oh; Y Koga; C M Sue; A Yamamoto; N Murakami; S Shanske; E Byrne; E Bonilla; I Nonaka; S DiMauro; M Hirano
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

6.  "Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews.

Authors:  Z Argov; R Yarom
Journal:  J Neurol Sci       Date:  1984-04       Impact factor: 3.181

7.  Familial cardiomyopathy, mental retardation and myopathy associated with desmin-type intermediate filaments.

Authors:  F Muntoni; G Catani; A Mateddu; M Rimoldi; T Congiu; G Faa; M G Marrosu; C Cianchetti; M Porcu
Journal:  Neuromuscul Disord       Date:  1994-05       Impact factor: 4.296

Review 8.  Clinicopathological features of genetically confirmed Danon disease.

Authors:  K Sugie; A Yamamoto; K Murayama; S J Oh; M Takahashi; M Mora; J E Riggs; J Colomer; C Iturriaga; A Meloni; C Lamperti; S Saitoh; E Byrne; S DiMauro; I Nonaka; M Hirano; I Nishino
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

9.  X-linked myopathy with excessive autophagy: a new hereditary muscle disease.

Authors:  H Kalimo; M L Savontaus; H Lang; L Paljärvi; V Sonninen; P B Dean; K Katevuo; A Salminen
Journal:  Ann Neurol       Date:  1988-03       Impact factor: 10.422

10.  Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy.

Authors:  K Kannan; S G Divers; A A Lurie; R Chervenak; M Fukuda; R F Holcombe
Journal:  Eur J Haematol       Date:  1995-09       Impact factor: 2.997

View more
  31 in total

1.  LAMP2 microdeletions in patients with Danon disease.

Authors:  Zhao Yang; Birgit H Funke; Linda H Cripe; G Wesley Vick; Debora Mancini-Dinardo; Liana S Peña; Ronald J Kanter; Brenda Wong; Brandy H Westerfield; Jaquelin J Varela; Yuxin Fan; Jeffrey A Towbin; Matteo Vatta
Journal:  Circ Cardiovasc Genet       Date:  2010-02-20

2.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 3.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

Review 5.  Myocardial autophagic energy stress responses--macroautophagy, mitophagy, and glycophagy.

Authors:  Lea M D Delbridge; Kimberley M Mellor; David J R Taylor; Roberta A Gottlieb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

Review 6.  Mechanisms and function of autophagy in intestinal disease.

Authors:  Kara G Lassen; Ramnik J Xavier
Journal:  Autophagy       Date:  2018-01-29       Impact factor: 16.016

Review 7.  Autophagic stress in neuronal injury and disease.

Authors:  Charleen T Chu
Journal:  J Neuropathol Exp Neurol       Date:  2006-05       Impact factor: 3.685

8.  EZH2 inhibitors transcriptionally upregulate cytotoxic autophagy and cytoprotective unfolded protein response in human colorectal cancer cells.

Authors:  Yao-Yu Hsieh; Hsiang-Ling Lo; Pei-Ming Yang
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 9.  Autophagy and neurodegeneration.

Authors:  Annamaria Ventruti; Ana Maria Cuervo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

10.  Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease.

Authors:  Nina Raben; Victoria Hill; Lauren Shea; Shoichi Takikita; Rebecca Baum; Noboru Mizushima; Evelyn Ralston; Paul Plotz
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.